Omalizumab - systemic asthma and rhinitis therapy in the new millennium

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1284, 2001-01, pp. : 7-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Omalizumab effective in allergic asthma and allergic rhinitis

By  

Inpharma, Vol. 1, Iss. 1408, 2003-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

INNOVATEive omalizumab therapy effective in difficult-to-treat asthma

By  

Inpharma, Vol. 1, Iss. 1488, 2005-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Omalizumab is an effective add-on therapy in moderate-to-severe allergic asthma

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 21, Iss. 7, 2005-07 ,pp. : 1-4

Adis International

Access to resources Recommend Favorite

Anti-IgE monoclonal antibody, omalizumab: a new treatment for allergic asthma

By Chung K Fan  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 2, 2004-02 ,pp. : 439-446

Informa Healthcare

Access to resources Recommend Favorite

Systemic levels of ceruloplasmin oxidase activity in allergic asthma and allergic rhinitis

By Yalcin Arzu Didem  

Immunopharmacology and Immunotoxicology, Vol. 34, Iss. 6, 2012-12 ,pp. : 1047-1053

Informa Healthcare

Access to resources Recommend Favorite